Market Closed -
Other stock markets
|
After market 12:24:43 pm | |||
24.37 EUR | -0.33% | 24.36 | -0.06% |
Jun. 07 | PHILIPS NV : Goldman Sachs keeps its Buy rating | ZD |
Jun. 04 | Royal Philips Introduces AI-Powered Cardiovascular Ultrasound Platform | MT |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
- From a short-term investment perspective, the company presents a deteriorated fundamental configuration.
- The company's Refinitiv ESG score, based on a ranking of the company relative to its industry, comes out particularly well.
Strengths
- The company's earnings per share (EPS) are expected to grow significantly over the next few years according to the consensus of analysts covering the stock.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- The opinion of analysts covering the stock has improved over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 124.79 times its estimated earnings per share for the ongoing year.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- For the past year, analysts have significantly revised downwards their profit estimates.
- For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
- Prospects from analysts covering the stock are not consistent. Such dispersed sales estimates confirm the poor visibility into the group's activity.
- The company's earnings releases usually do not meet expectations.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+19.09% | 24.62B | B | ||
+8.45% | 222B | B | ||
+23.79% | 148B | B- | ||
+32.97% | 114B | A- | ||
+4.30% | 65.69B | A- | ||
+12.96% | 51.88B | B+ | ||
+3.16% | 50.02B | B+ | ||
-5.30% | 38.81B | A | ||
-3.39% | 34.59B | - | ||
+21.43% | 31.09B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- PHIA Stock
- Ratings Philips NV